Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2003
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
L M Jost,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for the management of cancer pain
L M Jost,
Therapeutische Umschau. Revue Therapeutique
|
August 1, 1997
[Tumor screening with special reference to breast and prostate carcinoma]
L M Jost
Onkologie
|
April 1, 1990
[Overdose with melphalan (Alkeran): symptoms and treatment. A review]
L M Jost
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO recommendations for the application of hematopoietic growth factors
R Greil, L M Jost,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma
L M Jost, R A Stahel,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease
L M Jost, R A Stahel,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
L M Jost, S Jelic, G Purkalne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer
R Herrmann, L M Jost, N Pavlidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy
L M Jost, G Pichert, R A Stahel
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2003
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
L M Jost,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for the management of cancer pain
L M Jost,
Therapeutische Umschau. Revue Therapeutique
|
August 1, 1997
[Tumor screening with special reference to breast and prostate carcinoma]
L M Jost
Onkologie
|
April 1, 1990
[Overdose with melphalan (Alkeran): symptoms and treatment. A review]
L M Jost
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO recommendations for the application of hematopoietic growth factors
R Greil, L M Jost,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of relapsed large cell non-Hodgkin's lymphoma
L M Jost, R A Stahel,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease
L M Jost, R A Stahel,
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma
L M Jost, S Jelic, G Purkalne, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 13, 2005
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer
R Herrmann, L M Jost, N Pavlidis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 1990
Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy
L M Jost, G Pichert, R A Stahel
Page
of 4